Skip to main content

  • Polymer-Free Biolimus-Eluting Stents or Polymer-Based Zotarolimus-Eluting Stents for Coronary Bifurcation Lesions

    • Posted: 02/28/2022
    • Author:

      Guglielmo Gallone, Fabrizio D'Ascenzo, Alfonso Ielasi, Federico Landra, Giulio G. Stefanini, Maurizio Di Biasi, Massimo Mancone, Fabrizio Tomai, Vincenzo Infantino, Andrea Rognoni, Carlo Briguori, Giacomo Boccuzzi, Grzegorz Smolka, Mauro Chiarito, Davide Capodanno, Alaide Chieffo, Franco Fabbiocchi, Arnaldo Poli, Maurizio Tespili, Maurizio D'Urbano, Arturo Giordano, Javier Escaned, Gaetano M. De Ferrari and Gennaro Sardella

    • CRM2022

    Abstract

    Background

    A polymer-free biolimus-eluting stent (PF-BES) and a zotarolimus-eluting stent (ZES) recently showed similar clinical profiles and appear to be competing options in specific clinical settings of patients undergoing percutaneous coronary intervention (PCI). Whether they perform similarly also in complex procedural settings as coronary bifurcation lesions remains unaddressed.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details